Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03DRL
|
||||
Former ID |
DNC004734
|
||||
Drug Name |
Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Thr12]SRIF
|
||||
Indication | Discovery agent | Investigative | [527384] | ||
Structure |
Download2D MOL |
||||
Formula |
C77H99N13O15S2
|
||||
Canonical SMILES |
CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC<br />(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)<br />CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)<br />C(=O)O)CO)C(C)O)C)CC7=CC=CC=C7)C(C)O
|
||||
InChI |
1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)38-60-72(99)89-65(46(3)92)74(101)86-62(39-50-23-13-8-14-24-50)76(103)90(5)66(47(4)93)75(102)87-63(42-91)73(100)88-64(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-61(71(98)84-60)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,98)(H,85,97)(H,86,101)(H,87,102)(H,88,100)(H,89,99)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1
|
||||
InChIKey |
NJKZOMFLMSOAAY-PCKPOTSRSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 4 | Target Info | Inhibitor | [527384] | |
Somatostatin receptor 1 | Target Info | Inhibitor | [527384] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.